Advertisement

Trends in myopia management attitudes and strategies in clinical practice: Survey of eye care practitioners in Africa

Published:April 12, 2022DOI:https://doi.org/10.1016/j.clae.2022.101597

      Abstract

      Purpose

      There remains a lack of information on the perception and adoption of myopia control strategies among African eye care practitioners (ECPs). This study provides an African perspective to similar previous studies conducted in other parts of the world.

      Methods

      A self-administered survey in English and French was distributed to ECPs across Africa. The items on the questionnaire assessed their level of concern about the increasing prevalence of paediatric myopia, perceived efficacy, opinions on, and adoption of various myopia management modalities.

      Results

      Responses were obtained from 330 ECPs working in 23 African countries. Respondents were highly concerned about the increasing prevalence of paediatric myopia in their clinic (median 8/10) and perceived approved myopia control soft contact lenses as the most effective at slowing myopia progression (mean perceived reduction in myopia progression ± SD; 53.9 ± 27.1%), followed by single vision spectacles (53.1 ± 30.9%), and orthokeratology (52.8 ± 28.0%). Multifocal soft contact lenses (40.4 ± 25.8%) and pharmaceutical agents such as topical atropine drops (39.5 ± 27.1%) were perceived as least effective in slowing myopia progression. Although ECPs reported being aware of various myopia control strategies, they still mainly prescribed single vision spectacles to a large proportion (64.3 ± 29.9%) of young progressing myopes. Nearly one-third (27%) of ECPs who prescribed single vision lenses stated they were concerned about the cost implications to patients. Other reported concerns included safety of, and inadequate information about myopia control options.

      Conclusions

      African ECPs continue to prescribe single vision lenses for progressing myopes despite being aware of the various myopia control options. Practitioners’ perceptions of the efficacy of several modalities to slow myopia progression do not align with the current best evidence. Clear practice guidelines and continuing education on myopia control are warranted to inform and guide the management of myopic patients in Africa.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Contact Lens and Anterior Eye
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Rudnicka A.R.
        • Kapetanakis V.V.
        • Wathern A.K.
        • Logan N.S.
        • Gilmartin B.
        • Whincup P.H.
        • et al.
        Global variations and time trends in the prevalence of childhood myopia, a systematic review and quantitative meta-analysis: implications for aetiology and early prevention.
        Br J Ophthalmol. 2016; 100: 882-890
        • Holden B.A.
        • Fricke T.R.
        • Wilson D.A.
        • Jong M.
        • Naidoo K.S.
        • Sankaridurg P.
        • et al.
        Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050.
        Ophthalmology. 2016; 123: 1036-1042
        • Sankaridurg P.
        • Tahhan N.
        • Kandel H.
        • Naduvilath T.
        • Zou H.
        • Frick K.D.
        • et al.
        IMI impact of myopia.
        Invest Ophthalmol Vis Sci. 2021; 62: 2
        • Holden B.
        • Sankaridurg P.
        • Smith E.
        • Aller T.
        • Jong M.
        • He M.
        Myopia, an underrated global challenge to vision: where the current data takes us on myopia control.
        Eye (Lond). 2014; 28: 142-146https://doi.org/10.1038/eye.2013.256
        • Flaxman S.R.
        • Bourne R.R.A.
        • Resnikoff S.
        • Ackland P.
        • Braithwaite T.
        • Cicinelli M.V.
        • et al.
        Global causes of blindness and distance vision impairment 1990–2020: a systematic review and meta-analysis.
        Lancet Glob Health. 2017; 5: e1221-e1234
        • Fricke T.R.
        • Holden B.A.
        • Wilson D.A.
        • Schlenther G.
        • Naidoo K.S.
        • Resnikoff S.
        • et al.
        Global cost of correcting vision impairment from uncorrected refractive error.
        Bull World Health Organ. 2012; 90: 728-738
        • Naidoo K.S.
        • Fricke T.R.
        • Frick K.D.
        • Jong M.
        • Naduvilath T.J.
        • Resnikoff S.
        • et al.
        Potential lost productivity resulting from the global burden of myopia: systematic review, meta-analysis, and modeling.
        Ophthalmology. 2019; 126: 338-346
        • Kawuma M.
        • Mayeku R.
        A survey of the prevalence of refractive errors among children in lower primary schools in Kampala district.
        Afr Health Sci. 2002; 2: 69-72
        • Naidoo K.S.
        • Raghunandan A.
        • Mashige K.P.
        • Govender P.
        • Holden B.A.
        • Pokharel G.P.
        • et al.
        Refractive error and visual impairment in African children in South Africa.
        Invest Ophthalmol Vis Sci. 2003; 44: 3764-3770https://doi.org/10.1167/iovs.03-0283
        • Ovenseri-Ogbomo G.O.
        • Assien R.
        Refractive error in school children in Agona Swedru, Ghana.
        Afr Vis Eye Health. 2010; 69: 7https://doi.org/10.4102/aveh.v69i2.129
        • Otutu M.
        • Nachega J.
        • Harvey J.
        • Meyer D.
        The prevalence of refractive error in three communities of Cape Town, South Africa.
        Afr Vis Eye Health. 2012; 71: 7https://doi.org/10.4102/aveh.v71i1.65
        • Kumah B.D.
        • Ebri A.
        • Abdul-Kabir M.
        • Ahmed A.-S.
        • Koomson N.Y.
        • Aikins S.
        • et al.
        Refractive error and visual impairment in private school children in Ghana.
        Optom Vis Sci. 2013; 90: 1456-1461
        • Kedir J.
        • Girma A.
        Prevalence of refractive error and visual impairment among rural school-age children of Goro District, Gurage Zone.
        Ethiopia Ethiop J Health Sci. 2014; 24: 353-358https://doi.org/10.4314/ejhs.v24i4.11
        • Balarabe A.
        • Adamu I.
        • Abubakar A.
        Vision screening to detect refractive errors in three selected secondary schools in Birnin Kebbi, North West.
        Nigeria Sahel Med J. 2015; 18: 61-65https://doi.org/10.4103/1118-8561.160799
        • Alrasheed S.H.
        • Naidoo K.S.
        • Clarke-Farr P.C.
        Prevalence of visual impairment and refractive error in school-aged children in South Darfur State of Sudan. African Vision and Eye.
        Health. 2016; 75https://doi.org/10.4102/aveh.v75i1.355
        • Tagoh S.
        • Kyei S.
        • Kwarteng M.A.
        • Aboagye E.
        Prevalence of refractive error and visual impairment among rural dwellers in mashonaland central Province.
        Zimbabwe J Curr Ophthalmol. 2020; 32: 402-407https://doi.org/10.4103/joco.Joco_224_20
        • Ip J.M.
        • Rose K.A.
        • Morgan I.G.
        • Burlutsky G.
        • Mitchell P.
        Myopia and the urban environment: findings in a sample of 12-year-old Australian school children.
        Invest Ophthalmol Vis Sci. 2008; 49: 3858-3863https://doi.org/10.1167/iovs.07-1451
        • Güneralp B.
        • Lwasa S.
        • Masundire H.
        • Parnell S.
        • Seto K.C.
        Urbanization in Africa: challenges and opportunities for conservation.
        Environ Res Lett. 2017; 13015002https://doi.org/10.1088/1748-9326/aa94fe
        • Chua W.-H.
        • Balakrishnan V.
        • Chan Y.-H.
        • Tong L.
        • Ling Y.
        • Quah B.-L.
        • et al.
        Atropine for the treatment of childhood myopia.
        Ophthalmology. 2006; 113: 2285-2291
        • Chia A.
        • Chua W.-H.
        • Cheung Y.-B.
        • Wong W.-L.
        • Lingham A.
        • Fong A.
        • et al.
        Atropine for the treatment of childhood myopia: safety and efficacy of 0.5%, 0.1%, and 0.01% doses (atropine for the treatment of myopia 2).
        Ophthalmology. 2012; 119: 347-354https://doi.org/10.1016/j.ophtha.2011.07.031
        • Yam J.C.
        • Jiang Y.
        • Tang S.M.
        • Law A.K.P.
        • Chan J.J.
        • Wong E.
        • et al.
        Low-concentration atropine for myopia progression (LAMP) study: a randomized, double-blinded, placebo-controlled trial of 0.05%, 0.025%, and 0.01% atropine eye drops in myopia control.
        Ophthalmology. 2019; 126: 113-124
        • Siatkowski R.M.
        • Cotter S.A.
        • Crockett R.S.
        • Miller J.M.
        • Novack G.D.
        • Zadnik K.
        • et al.
        Two-year multicenter, randomized, double-masked, placebo-controlled, parallel safety and efficacy study of 2% pirenzepine ophthalmic gel in children with myopia.
        J AAPOS. 2008; 12: 332-339https://doi.org/10.1016/j.jaapos.2007.10.014
        • Cho P.
        • Cheung S.W.
        Retardation of myopia in Orthokeratology (ROMIO) study: a 2-year randomized clinical trial.
        Invest Ophthalmol Vis Sci. 2012; 53: 7077-7085https://doi.org/10.1167/iovs.12-10565
        • Hiraoka T.
        • Kakita T.
        • Okamoto F.
        • Takahashi H.
        • Oshika T.
        Long-term effect of overnight orthokeratology on axial length elongation in childhood myopia: a 5-year follow-up study.
        Invest Ophthalmol Vis Sci. 2012; 53: 3913-3919https://doi.org/10.1167/iovs.11-8453
        • Lam C.S.Y.
        • Tang W.C.
        • Tse D.-Y.
        • Lee R.P.K.
        • Chun R.K.M.
        • Hasegawa K.
        • et al.
        Defocus Incorporated Multiple Segments (DIMS) spectacle lenses slow myopia progression: a 2-year randomised clinical trial.
        Br J Ophthalmol. 2020; 104: 363-368
        • Walline J.J.
        • Walker M.K.
        • Mutti D.O.
        • Jones-Jordan L.A.
        • Sinnott L.T.
        • Giannoni A.G.
        • et al.
        Effect of high add power, medium add power, or single-vision contact lenses on myopia progression in children: the BLINK randomized clinical trial.
        JAMA. 2020; 324: 571
        • Chamberlain P.
        • Peixoto-de-Matos S.C.
        • Logan N.S.
        • Ngo C.
        • Jones D.
        • Young G.
        A 3-year randomized clinical trial of MiSight lenses for myopia control.
        Optom Vis Sci. 2019; 96: 556-567https://doi.org/10.1097/OPX.0000000000001410
        • Guggenheim J.A.
        • Northstone K.
        • McMahon G.
        • Ness A.R.
        • Deere K.
        • Mattocks C.
        • et al.
        Time outdoors and physical activity as predictors of incident myopia in childhood: a prospective cohort study.
        Invest Ophthalmol Vis Sci. 2012; 53: 2856
        • He M.
        • Xiang F.
        • Zeng Y.
        • Mai J.
        • Chen Q.
        • Zhang J.
        • et al.
        Effect of time spent outdoors at school on the development of myopia among children in China: a randomized clinical trial.
        JAMA. 2015; 314: 1142
      1. Chia A, Chua WH, Wen L, Fong A, Goon YY, Tan D. Atropine for the treatment of childhood myopia: changes after stopping atropine 0.01%, 0.1% and 0.5%. Am J Ophthalmol 2014;157(2):451-7.e1. https://doi.org/10.1016/j.ajo.2013.09.020.

        • Chia A.
        • Lu Q.-S.
        • Tan D.
        Five-year clinical trial on atropine for the treatment of myopia 2: myopia control with atropine 0.01% eyedrops.
        Ophthalmology. 2016; 123: 391-399https://doi.org/10.1016/j.ophtha.2015.07.004
        • Gregory H.R.
        • Nti A.N.
        • Wolffsohn J.S.
        • Berntsen D.A.
        • Ritchey E.R.
        Visual performance of center-distance multifocal contact lenses fit using a myopia control paradigm.
        Optom Vis Sci. 2021; 98: 272-279https://doi.org/10.1097/OPX.0000000000001665
        • Garcia-Marques J.V.
        • Macedo-De-Araujo R.J.
        • Cervino A.
        • Garcia-Lazaro S.
        • McAlinden C.
        • Gonzalez-Meijome J.M.
        Comparison of short-term light disturbance, optical and visual performance outcomes between a myopia control contact lens and a single-vision contact lens.
        Ophthalmic Physiol Opt. 2020; 40: 718-727https://doi.org/10.1111/opo.12729
        • Berntsen D.A.
        • Barr J.T.
        • Mitchell G.L.
        The effect of overnight contact lens corneal reshaping on higher-order aberrations and best-corrected visual acuity.
        Optom Vis Sci. 2005; 82: 490-497https://doi.org/10.1097/01.opx.0000168586.36165.bb
        • Cho P.
        • Cheung S.W.
        Discontinuation of orthokeratology on eyeball elongation (DOEE).
        Cont Lens Anterior Eye. 2017; 40: 82-87https://doi.org/10.1016/j.clae.2016.12.002
        • Swarbrick H.A.
        • Alharbi A.
        • Watt K.
        • Lum E.
        • Kang P.
        Myopia control during orthokeratology lens wear in children using a novel study design.
        Ophthalmology. 2015; 122: 620-630https://doi.org/10.1016/j.ophtha.2014.09.028
        • Chen Z.
        • Zhou J.
        • Xue F.
        • Zhou X.
        • Qu X.
        Increased corneal toricity after long-term orthokeratology lens wear.
        J Ophthalmol. 2018; 2018: 7106028https://doi.org/10.1155/2018/7106028
        • Xiong S.
        • Sankaridurg P.
        • Naduvilath T.
        • Zang J.
        • Zou H.
        • Zhu J.
        • et al.
        Time spent in outdoor activities in relation to myopia prevention and control: a meta-analysis and systematic review.
        Acta Ophthalmol. 2017; 95: 551-566
        • Wolffsohn J.S.
        • Calossi A.
        • Cho P.
        • Gifford K.
        • Jones L.
        • Li M.
        • et al.
        Global trends in myopia management attitudes and strategies in clinical practice.
        Cont Lens Anterior Eye. 2016; 39: 106-116
        • Wolffsohn J.S.
        • Calossi A.
        • Cho P.
        • Gifford K.
        • Jones L.
        • Jones D.
        • et al.
        Global trends in myopia management attitudes and strategies in clinical practice - 2019 Update.
        Cont Lens Anterior Eye. 2020; 43: 9-17
        • Ekpenyong B.
        • Obinwanne C.J.
        • Ovenseri-Ogbomo G.
        • Ahaiwe K.
        • Lewis O.O.
        • Echendu D.C.
        • et al.
        Assessment of knowledge, practice and guidelines towards the novel COVID-19 among eye care practitioners in Nigeria-a survey-based study.
        Int J Environ Res Public Health. 2020; 17: 5141
        • Flitcroft D.I.
        The complex interactions of retinal, optical and environmental factors in myopia aetiology.
        Prog Retin Eye Res. 2012; 31: 622-660https://doi.org/10.1016/j.preteyeres.2012.06.004
        • Tran H.D.M.
        • Tran Y.H.
        • Tran T.D.
        • Jong M.
        • Coroneo M.
        • Sankaridurg P.
        A review of myopia control with atropine.
        J Ocul Pharmacol Ther. 2018; 34: 374-379https://doi.org/10.1089/jop.2017.0144
        • The Comet Group
        Myopia stabilization and associated factors among participants in the Correction of Myopia Evaluation Trial (COMET).
        Invest Ophthalmol Vis Sci. 2013; 54: 7871-7884https://doi.org/10.1167/iovs.13-12403
        • Logan N.S.
        • Wolffsohn J.S.
        Role of un-correction, under-correction and over-correction of myopia as a strategy for slowing myopic progression.
        Clin Exp Optom. 2020; 103: 133-137https://doi.org/10.1111/cxo.12978
        • Bullimore M.A.
        • Ritchey E.R.
        • Shah S.
        • Leveziel N.
        • Bourne R.R.A.
        • Flitcroft D.I.
        The risks and benefits of myopia control.
        Ophthalmology. 2021; 128: 1561-1579
        • Zhao C.
        • Cai C.
        • Ding Q.
        • Dai H.
        Efficacy and safety of atropine to control myopia progression: a systematic review and meta-analysis.
        BMC Ophthalmology. 2020; 20: 478https://doi.org/10.1186/s12886-020-01746-w
        • Ruiz-Pomeda A.
        • Prieto-Garrido F.L.
        • Hernández Verdejo J.L.
        • Villa-Collar C.
        Rebound effect in the misight assessment study Spain (Mass).
        Curr Eye Res. 2021; 46: 1223-1226https://doi.org/10.1080/02713683.2021.1878227
        • Berntsen D.A.
        • Sinnott L.T.
        • Mutti D.O.
        • Zadnik K.
        A randomized trial using progressive addition lenses to evaluate theories of myopia progression in children with a high lag of accommodation.
        Invest Ophthalmol Vis Sci. 2012; 53: 640-649https://doi.org/10.1167/iovs.11-7769
      2. Walline JJ, Lindsley KB, Vedula SS, Cotter SA, Mutti DO, Ng SM, et al. Interventions to slow progression of myopia in children. Cochrane Database Syst Rev 2020;1:CD004916. https://doi.org/10.1002/14651858.CD004916.pub4.

        • Bullimore M.A.
        • Brennan N.A.
        Myopia control: why each diopter matters.
        Optom Vis Sci. 2019; 96: 463-465https://doi.org/10.1097/opx.0000000000001367
        • Asiedu K.
        • Kyei S.
        • Ayobi B.
        • Agyemang F.O.
        • Ablordeppey R.K.
        Survey of eye practitioners' preference of diagnostic tests and treatment modalities for dry eye in Ghana.
        Cont Lens Anterior Eye. 2016; 39: 411-415https://doi.org/10.1016/j.clae.2016.08.001
        • Boadi-Kusi S.B.
        • Kyei S.
        • Ocansey S.
        • Ntodie M.
        • Ofori-Agyei D.-B.
        • Mashige K.P.
        Assessment of infection prevention and control measures adopted by eye care practitioners in Ghana and South Africa against COVID-19.
        Scientific African. 2021; 12e00766https://doi.org/10.1016/j.sciaf.2021.e00766
        • Wolffsohn J.S.
        • Jong M.
        • Smith E.L.
        • Resnikoff S.R.
        • Jonas J.B.
        • Logan N.S.
        • et al.
        IMI 2021 reports and digest – reflections on the implications for clinical practice.
        Invest Ophthalmol Vis Sci. 2021; 62: 1
        • Wolffsohn J.S.
        • Flitcroft D.I.
        • Gifford K.L.
        • Jong M.
        • Jones L.
        • Klaver C.C.W.
        • et al.
        IMI – myopia control reports overview and introduction.
        Invest Ophthalmol Vis Sci. 2019; 60: M1